These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 3531415)
21. C825T polymorphism of the G protein beta3 subunit is associated with obesity but not with insulin sensitivity. Stefan N; Stumvoll M; Machicao F; Koch M; Häring HU; Fritsche A Obes Res; 2004 Apr; 12(4):679-83. PubMed ID: 15090636 [TBL] [Abstract][Full Text] [Related]
22. [Assessment of selected markers of inflammation in patients with clinical symptoms of insulin resistance and normal renal function]. Bogdański P; Pupek-Musialik D; Luczak M; Szulińska M Pol Merkur Lekarski; 2006 Aug; 21(122):165-8; discussion 169. PubMed ID: 17144103 [TBL] [Abstract][Full Text] [Related]
23. Is visceral obesity the cause of the metabolic syndrome? Després JP Ann Med; 2006; 38(1):52-63. PubMed ID: 16448989 [TBL] [Abstract][Full Text] [Related]
24. [Arterial hypertension and obesity--a dangerous combination]. Zakharieva S Vutr Boles; 1999; 31(1):28-32. PubMed ID: 10847146 [TBL] [Abstract][Full Text] [Related]
25. Growth hormone and the metabolic syndrome. Johannsson G; Bengtsson BA J Endocrinol Invest; 1999; 22(5 Suppl):41-6. PubMed ID: 10442570 [TBL] [Abstract][Full Text] [Related]
26. Metabolic fluxes in skeletal muscle in relation to obesity and insulin resistance. Blaak EE Best Pract Res Clin Endocrinol Metab; 2005 Sep; 19(3):391-403. PubMed ID: 16150382 [TBL] [Abstract][Full Text] [Related]
27. Skeletal muscle utilization of free fatty acids in women with visceral obesity. Colberg SR; Simoneau JA; Thaete FL; Kelley DE J Clin Invest; 1995 Apr; 95(4):1846-53. PubMed ID: 7706491 [TBL] [Abstract][Full Text] [Related]
28. Adipotoxicity and the insulin resistance syndrome. Anderwald C; Roden M Pediatr Endocrinol Rev; 2004 Mar; 1(3):310-9. PubMed ID: 16437024 [TBL] [Abstract][Full Text] [Related]
29. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity. Smith SR; Lovejoy JC; Greenway F; Ryan D; deJonge L; de la Bretonne J; Volafova J; Bray GA Metabolism; 2001 Apr; 50(4):425-35. PubMed ID: 11288037 [TBL] [Abstract][Full Text] [Related]
30. [Psychosomatic aspects of essential hypertension]. Reindell A; Petzold E; Schütz P; Matthes D Med Klin; 1979 Feb; 74(6):182-90. PubMed ID: 763211 [No Abstract] [Full Text] [Related]
31. [Drug information for nurses. Obesity; therapeutic main group: anorectics, appetite depressants. 3. Complications of obesity]. Lumholtz IB Sygeplejersken; 1976 Oct; 76(40):11. PubMed ID: 1050119 [No Abstract] [Full Text] [Related]
32. Nonesterified fatty acids in the pathogenesis of hypertension: theory and evidence. Goodfriend TL; Egan BM Prostaglandins Leukot Essent Fatty Acids; 1997 Jul; 57(1):57-63. PubMed ID: 9250609 [TBL] [Abstract][Full Text] [Related]
37. [The relationship between juvenile obesity and the development of hypertension]. Reuter G Z Gesamte Hyg; 1977; 23(6):427-9. PubMed ID: 899086 [No Abstract] [Full Text] [Related]
39. Obesity and hypertension: conclusions and recommendations. Berchtold P; Sims EA Int J Obes; 1981; 5 suppl 1():183-4. PubMed ID: 7016784 [No Abstract] [Full Text] [Related]
40. Prevalence of obesity in patients with essential hypertension of varying severity. Haider Z; Bano KA J Pak Med Assoc; 1985 Dec; 35(12):354-7. PubMed ID: 3937908 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]